HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 2, 2000, Pages 184-193

  Bongertz, V ^a   Bou Habib, D C ^a   Brigido L F M ^b   Caseiro, M ^c   Chequer, P J N ^d   Couto Fernandez, J C ^a   Ferreira, P C ^e   Galvao Castro B ^a   Greco, D ^e   Guimaraes M L ^a   Linhares De Carvalho, M I ^f   Morgado, M G ^a   Oliveira, C A F ^b   Osmanov, S ^g   Ramos, C A ^h   Rossini, M ^b   Sabino, E ^b   Tanuri, A ^h   Ueda, M ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Hospital Casa de Saude de Santos   (Brazil)

^d MINISTÉRIO DA SAÚDE   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f Ambulatorio do Banco da Providencia   (Brazil)

^g UNAIDS   (Switzerland)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brazil; HIV 1; Polymorphism Molecular epidemiology

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CHARACTERIZATION; VIRUS ISOLATION;

EID: 12944259137     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200002010-00011     Document Type: Article

References (53)

1. UNAIDS/WHO. AIDS epidemic update: December 1998. Geneva, Switzerland: UNAIDS/WHO, 1998.
2. Caceres CF, Hearst N. HIV/AIDS in Latin America and the Caribbean: an update. AIDS 1996;10(Suppl A):S43-9.
3. Hendry RM, Parks DE, Mello DL, Quinnan GV, Galvão-Castro B. Lack of evidence for HIV-2 infection among at risk individuals in Brazil. J Acquir Immune Defic Syndr 1991;4:623-7.
4. Aids Boletim Epidemiológico. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS Ministério da Saúde. Aids Boletin Epidemiológico, Ano XI 1998;4:5.
5. Mann JM, Tarantola D (Eds). AIDS in the world II/The AIDS Policy Coalition. New York: Oxford University Press, 1996.
6. Expert Group of the Joint United Nations Programme on HIV/ AIDS. Implications of HIV variability for transmission: scientific and policy issues. AIDS 1997;11:UNAIDS1-15.
7. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/ AIDS. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. AIDS 1997;11:UNAIDS17-36.
8. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research and prevention. JAMA 1996;275:210-16.
9. Carr JK, Foley BT, Leitner T, Salminen M, Kober B, McCutchan F. Reference sequences representing the principal genetic diversity of HIV-1 In the Pandemic. In Kober B, Kuiken C, Foley B, Hahn B, Mellors J, Sodroski J. Human retroviruses and AIDS: theoretical biology and biophysics. Los Alamos, NM: Los Alamos National Laboratory, 1998:III-9.
10. Myers G. Human retroviruses and AIDS. Los Alamos: Los Alamos National Laboratory, Department of Theoretical Biology and Biophysics, 1996.
11. Gurtler LG, Hauser PH, Eberle J, et al. A new subtype of human immunodeficiency virus type 1 (MVP 5180) from Cameroon. J Virol 1994;68:1581-5.
12. Loussert-Ajaka I, Chaix ML, Korber B, et al. Variability of human immunodeficiency type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-9.
13. Simon F, Mauclère P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-7.
14. Sabino EC, Shpaer EG, Morgado MG, et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994;68:6340-6.
15. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995;40:249-59.
16. Gao F, Morrison SG, Robertson DL, et al. and the WHO and NIAID Networks for HIV Isolation and Characterization. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J Virol 1996;70:1651-67.
17. Mc Cutchan FE, Salminen MO, Carr JK, Burke DS. HIV-1 genetic diversity. AIDS 1996;10(Suppl 3):S13-20.
18. Salminen MO, Carr JK, Robertson DL, et al. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol 1997;71:2647-55.
19. Gao F, Robertson DL, Morrison SG, et al. The Heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (AiE) recombinant of African origin. J Virol 1996;70:7013-29.
20. Bobkov AF, Pokrovskii W, Selimova LM, et al. Genotyping and phylogenetic analysis of HIV-1 isolates circulating in Russia. Vopr Virusol 1997;42:13-6.
21. Map monitoring the AIDS pandemic: the status and trends of the HIV/AIDS/STD epidemics in Latin America and the Caribbean, November 4-5, 1997.
22. Potts KE, Kalish ML, Lott T, et al. and the Brazilian Collaborative AIDS Research group. Genetic Heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. AIDS 1993;7:1191-7.
23. Morgado MG, Sabino EC, Shpaer EG, et al. V3 region polymorphism in HIV-1 from Brazil: prevalence of subtype B strains divergent from the North American/European prototype and detection of subtypes F. AIDS Res Hum Retroviruses 1994;10:569-75.
24. WHO Network for HIV Isolation and Characterization. HIV-1 type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994;10:1327-43.
25. Artenstein AW, Coppola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into western hemisphere. Lancet 1995; 346:1197-8.
26. Campodonico ME, Fay F, Taborda M, Janssens W, Heyndrickx L, Fay O. Evidence of the presence of HIV-1 subtype "C" strains in Argentina [abstract Tua 2052]. Presented at the XI International Conference on AIDS, Vancouver, 1996.
27. Marquina S, Leitner T, Rabinovich RD, Benetucci J, Libonatti, Albert J. Coexistence of subtype B, F and B/F env Recombinant of HIV Type 1 in Buenos Aires, Argentina. AIDS Res Human Retroviruses 1996;12:1651-4.
28. Velarde KG, Guimarães ML, Arevalo R, Morgado MG. Molecular characterization of human immunodeficiency virus type 1 infected individuals from Bolivia reveals presence of two distinct genetic subtypes [abstract Tua 12178]. Presented at the XII International Conference on AIDS, Geneva, 1998.
29. Morgado MG, Guimarães ML, Gripp CBG, et al. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the City of Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:488-94.
30. Janini LM, Pierniazek D, Peralta JM, et al. Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes 1996;13:69-81.
31. Morgado MG, Guimarães ML, Neves Jr, et al. Molecular epidemiology of HIV in Brazil: polymorphism of the antigenically distinct HIV-1 B subtype strains. Mem Inst Oswaldo Cruz 1998;93: 383-6.
32. Covas DT, Bíscaro TA, Kashima S, Duarte G, Machado AA. High frequency of the GWG (Pro Tip) envelope variant of HIV-1 in Southeast Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:74-9.
33. Korber BTM, Osmanov S, Esparza J, Myers G, and the WHO Network for HIV Isolation and characterization. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. AIDS Res Hum Retroviruses 1994;10:1355-8.
34. Rübsamen-Waigmann H, Von Briesen H, Holmes H, et al. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. AIDS Res Hum Retroviruses 1994;10:1401-8.
35. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Ruebsamen-Waigmann H, Mullins J. Genetic relationships determined by a DNA heteroduplex motility assay: analysis of HIV-1 env genes. Science 1993;262:1257-61.
36. Delwart EL, Herring B, Learn Jr GH, Rodrigo AG, Mullins JI. Heteroduplex mobility analysis HIV-1 env subtyping kit, protocol version 3. Bethesda, MD: US National Institutes of Health AIDS Research and Reference Program, 1995.
37. Felsenstein J. PHYLIP - Philogeny Inference Package. Cladistics 1989;5:164-6.
38. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-25.
39. Bongertz V, Guimarães ML, Soares-da-Costa MFG, et al. Anti-HIV-1 seroreactivity and HIV transmission route. J Clin Virol 1999;12:37-42.
40. Moore JP, Mc Cutchan FE, Poon SW, et al. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol 1994;68:8350-64.
41. Albert J, Abrahamsson B, Nagy K, et al. Rapid development of isolate-specific neutralizing antibodies, after primary HIV infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990;4:107-12.
42. Bongertz V, Costa CI, Guimarães ML, Grinsztejn B, et al. and the Hospital Evandro Chagas AIDS Clinical Research Group. Neutralization susceptibility of B subtype variant B″ primary isolates. Scand J Immunol 1998;47:603-8.
43. Bandea CL, Ramos A, Pieniazek D, et al. Epidemiological and evolutionary relationship between Romanian and Brazilian HIV-1 subtypes F strains. Emerg Infect Dis 1995;1:91-3.
44. De Wolf F, Hogervost E, Goudsmit J, et al. Syncytium-inducing and non-syncytium-inducing capacity of Human Immunodeficiency Virus Type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994;10:1387-1400.
45. Couto-Fernandez JC, Morgado MG, Bongertz V, et al. HIV-1 Subtyping in Salvador-Bahia, Brazil: a city with African sociodemographic characteristics. J Acquir Immune Defic Syndr Hum Retrovirol 1999;22:288-93.
46. AIDS in Brazil: a joint government and society endeavor, Geneva, June 28-July 03, 1998 National Program of STD/AIDS, Brasilia: Ministry of Health, 1998.
47. Weniger BG, Takebe Y, Ou CY, Yamasaki S. The molecular epidemiology of HIV in ASIA. AIDS 1994;8(Suppl 2):S13-S28.
48. Wasi C, Herring B, Raktham S, et al. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and Heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995;9:843-9.
49. Hattori T, Shiozaki K, Eda Y, et al. Characteristics of the principal neutralizing determinant of HIV-I prevalent in Japan. AIDS Res Hum Retroviruses 1991;7:825-30.
50. Cheingsong-Popov R, Osmanov S, Pau CP, et al. Serotyping of HIV infections: definition, relationship of viral genetic subtypes and assay evaluation. AIDS Res Hum Retroviruses 1998;14:311-8.
51. Ferraro GA, Mello MA, Galvão-Castro B, Bou-Habib DC and The Brazilian Network for HIV-1 Isolation and Characterization. Cell tropism and chemokine receptor usage of HIV-1 isolates prevalent in Brazil [abstract 204]. Abstracts of the 1999 International Meeting of the Institute of Human Virology. J Human Virol 1999;2:208.
52. Kostrikis LG, Cao Y, Ngai H, Moore JP, Hp DD. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol 1996;70:445-58.
53. Moore JP, Cao Y, Leu J, Qin L, Korber B, Ho DD. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol 1996; 70:427-44.